Regulatory Material +

Verano Founder and Chief Executive Officer George Archos Celebrates Historic Announcement Confirming Cannabis Rescheduling to Schedule III

Verano Secures Regulatory Tailwind as Schedule III Confirmation Removes 280E Tax Overhang

By The Northwire Desk — AI Analysis Apr 23, 2026 · 09:55 VRNO · 1.79 VERANO HOLDINGS CORP.

Executive Summary

Headline: Verano Founder and Chief Executive Officer George Archos Celebrates Historic Announcement Confirming Cannabis Rescheduling to Schedule III.
Date: April 23, 2026.
Core Event: The Controlled Substances Act officially reschedules cannabis from Schedule I to Schedule III.
Management Commentary: CEO George Archos credits President Trump and Attorney General Blanche for the change, stating it unlocks medical, research, and commercial potential.
Context: This follows an Executive Order mentioned in December 2025 (NewsID: 83425) which directed the DOJ to reclassify cannabis. The April 2026 release confirms the completion of this regulatory process.

Material Impact

Regulatory Shift: Rescheduling to Schedule III is a fundamental structural change for US MSOs. It effectively removes the Section 280E tax code restriction, which currently prohibits federal tax deductions for businesses trafficking in controlled substances (Schedule I/II).
Financial Implication: For Verano, reporting $822M revenue and a net loss of $(258)M in FY 2025, the removal of 280E could materially improve effective tax rates and bottom-line profitability. Adjusted EBITDA was positive ($229M), suggesting core operations are viable once tax penalties are removed.
Market Expectation: The market had anticipated this move since the December 18, 2025 announcement of the Executive Order. The stock rallied from ~$1.03 in early December to a high of $1.74 by mid-December 2025. The April confirmation is the finalization of that expectation rather than new surprise information.
Risk Mitigation: While positive, the news does not address immediate liquidity constraints or debt servicing costs. The company carries significant leverage ($400M net debt) against $83M cash.
Conclusion: This is a Material - Positive event because it fundamentally alters the valuation model for US cannabis operators from distressed to normalized growth, though much of the initial sentiment was priced in during late 2025.

VRNO · Price

Company Overview

Overview: Verano Holdings Corp. is a leading US Multi-State Operator (MSO) operating in 13 states with 160 dispensaries and 15 production facilities as of Q4 2025.
Flagship Brands/Operations: Operates Zen Leaf (dispensaries), MÜV, Essence, Savvy, and BITS brands. Recently launched HYPHEN pod system and Swift Lifts pre-roll brand.
Geographic Footprint: Significant presence in Florida (83 dispensaries), Illinois, Maryland, New Jersey, Nevada, Ohio, and West Virginia. Recently secured a conditional vertical license for Texas.
Redomiciliation: Completed redomicile from British Columbia to Nevada (October 2025) to align with US regulatory environment and facilitate potential US exchange listing.

More from VERANO HOLDINGS CORP.